{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T10:28:39Z","timestamp":1792319319590,"version":"4.4.0"},"reference-count":205,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Lung cancer (LC) and tuberculosis (TB) represent two major global public health issues. Prior evidence has suggested a link between TB infection and an increased risk of LC. As advancements in LC treatment have led to extended survival rates for LC patients, the co-occurrence of TB and LC has grown more prevalent and poses novel clinical challenges. The intricate molecular mechanisms connecting TB and LC are closely intertwined and many issues remain to be addressed. This review focuses on resemblance between the immunosuppression in tumor and granuloma microenvironments, exploring immunometabolism, cell plasticity, inflammatory signaling pathways, microbiomics, and up-to-date information derived from spatial multi-omics between TB and LC. Furthermore, we outline immunization-related molecular mechanisms underlying these two diseases and propose future research directions. By discussing recent advances and potential targets, this review aims to establish a foundation for developing future therapeutic strategies targeting LC with concurrent TB infection.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1561719","type":"journal-article","created":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T02:42:14Z","timestamp":1743561734000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":20,"title":["Where lung cancer and tuberculosis intersect: recent advances"],"prefix":"10.3389","volume":"16","author":[{"given":"Chunju","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanlu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinglan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daishun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B2","volume-title":"Global tuberculosis report 2024","author":"Adam","year":"2024"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1700157","DOI":"10.1183\/13993003.00157-2017","article-title":"Risk of tuberculosis in patients with solid cancers and haematological Malignancies: a systematic review and meta-analysis","volume":"50","author":"Dobler","year":"2017","journal-title":"Eur Respir J"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw838","article-title":"Risk of active tuberculosis in patients with cancer: A systematic review and meta-analysis","volume":"64","author":"Cheng","year":"2017","journal-title":"Clin Infect Dis"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004919","article-title":"Cancer-specific incidence rates of tuberculosis: A 5-year nationwide population-based study in a country with an intermediate tuberculosis burden","volume":"95","author":"Seo","year":"2016","journal-title":"Med (Baltimore)"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2017.03.012","article-title":"Increased risk of active tuberculosis after cancer diagnosis","volume":"74","author":"Simonsen","year":"2017","journal-title":"J Infect"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2016.07.006","article-title":"Anti-PD1 antibody treatment and the development of acute pulmonary tuberculosis","volume":"11","author":"Fujita","year":"2016","journal-title":"J Thorac Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002960","article-title":"Risk of tuberculosis in patients with cancer treated with immune checkpoint inhibitors: a nationwide observational study","volume":"9","author":"Bae","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aat2702","article-title":"Tuberculosis following PD-1 blockade for cancer immunotherapy","volume":"11","author":"Barber","year":"2019","journal-title":"Sci Transl Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30674-6","article-title":"Immune checkpoint inhibitors and tuberculosis: an old disease in a new context","volume":"21","author":"Langan","year":"2020","journal-title":"Lancet Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyad340","article-title":"Increased tuberculosis reactivation risk in patients receiving immune checkpoint inhibitor-based therapy","volume":"29","author":"Chen","year":"2024","journal-title":"Oncologist"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2020.03.015","article-title":"Immune checkpoint inhibitor use and tuberculosis: a systematic review of the literature","volume":"132","author":"Zaemes","year":"2020","journal-title":"Eur J Cancer"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1162190","article-title":"Tuberculosis infection following immune checkpoint inhibitor treatment for advanced cancer: a case report and literature review","volume":"14","author":"Lin","year":"2023","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa126","article-title":"Incidence of active tuberculosis in lung cancer patients receiving immune checkpoint inhibitors","volume":"7","author":"Fujita","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1136\/esmoopen-2020-000866","article-title":"Mycobacterial infections due to PD-1 and PD-L1 checkpoint inhibitors","volume":"5","author":"Anand","year":"2020","journal-title":"ESMO Open"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2019.105853","article-title":"Development of tuberculosis in cancer patients receiving immune checkpoint inhibitors","volume":"161","author":"Im","year":"2020","journal-title":"Respir Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2020.05.020","article-title":"Immune checkpoint inhibition for non-small cell lung cancer in patients with pulmonary tuberculosis or Hepatitis B: Experience from a single Asian centre","volume":"146","author":"Chan","year":"2020","journal-title":"Lung Cancer"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.727220","article-title":"Increased tuberculosis incidence due to immunotherapy based on PD-1 and PD-L1 blockade: A systematic review and meta-analysis","volume":"13","author":"Liu","year":"2022","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1097\/00007611-198803000-00013","article-title":"Lung cancer, tuberculin reactivity, and isoniazid","volume":"81","author":"Alhashimi","year":"1988","journal-title":"South Med J"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1843.2008.01282.x","article-title":"Solid-organ Malignancy as a risk factor for tuberculosis","volume":"13","author":"Kim","year":"2008","journal-title":"Respirology"},{"key":"B21","article-title":"Aerodigestive tract, lung and haematological cancers are risk factors for tuberculosis: an 8-year population-based study","volume":"15","author":"Wu","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad373","article-title":"Increased lung cancer risk and associated risk factors in tuberculosis survivors: A korean population-based study","volume":"77","author":"Moon","year":"2023","journal-title":"Clin Infect Dis"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0250531","article-title":"Increased risk of secondary lung cancer in patients with tuberculosis: A nationwide, population-based cohort study","volume":"16","author":"Ho","year":"2021","journal-title":"PloS One"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.24042","article-title":"Tuberculosis and subsequent risk of lung cancer in Xuanwei, China","volume":"124","author":"Engels","year":"2009","journal-title":"Int J Cancer"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.25616","article-title":"Pulmonary tuberculosis increases the risk of lung cancer: a population-based cohort study","volume":"117","author":"Wu","year":"2011","journal-title":"Cancer"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e3181fb4fcc","article-title":"Increased lung cancer risk among patients with pulmonary tuberculosis: A population cohort study","volume":"6","author":"Yu","year":"2011","journal-title":"J Thorac Oncol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"220025","DOI":"10.1183\/16000617.0025-2022","article-title":"Lung cancer occurrence after an episode of tuberculosis: a systematic review and meta-analysis","volume":"31","author":"Cabrera-Sanchez","year":"2022","journal-title":"Eur Respir Rev"},{"key":"B28","doi-asserted-by":"publisher","first-page":"765","DOI":"10.3390\/jcm11030765","article-title":"Pulmonary tuberculosis and risk of lung cancer: A systematic review and meta-analysis","volume":"11","author":"Hwang","year":"2022","journal-title":"J Clin Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000543319","article-title":"Pulmonary tuberculosis and risk of lung cancer: A systematic review and meta-analysis","author":"Sodeifian","year":"2024","journal-title":"Respiration"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.30384","article-title":"Tuberculosis, smoking and risk for lung cancer incidence and mortality","volume":"139","author":"Hong","year":"2016","journal-title":"Int J Cancer"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/med4.58","article-title":"Visualization analysis of research progress and trends in coexistence of lung cancer and pulmonary tuberculosis using bibliometrics","volume":"2","author":"Yang","year":"2024","journal-title":"Med Adv"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)00367-2","article-title":"Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"B33","doi-asserted-by":"publisher","first-page":"6136","DOI":"10.3390\/ijms21176136","article-title":"Tuberculosis-cancer parallels in immune response regulation","volume":"21","author":"Bickett","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-023-00846-y","article-title":"Myeloid-derived suppressor cells in cancer and cancer therapy","volume":"21","author":"Lasser","year":"2024","journal-title":"Nat Rev Clin Oncol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-023-00657-4","article-title":"Multiplex protein imaging in tumour biology","volume":"24","author":"de Souza","year":"2024","journal-title":"Nat Rev Cancer"},{"key":"B36","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s12967-024-05035-8","article-title":"Spatial insights into immunotherapy response in non-small cell lung cancer (NSCLC) by multiplexed tissue imaging","volume":"22","author":"Monkman","year":"2024","journal-title":"J Transl Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-024-01529-6","article-title":"FFAR2 expressing myeloid-derived suppressor cells drive cancer immunoevasion","volume":"17","author":"Zhao","year":"2024","journal-title":"J Hematol Oncol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05672-3","article-title":"Single-cell spatial landscapes of the lung tumour immune microenvironment","volume":"614","author":"Sorin","year":"2023","journal-title":"Nature"},{"key":"B39","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/35095558","article-title":"How can immunology contribute to the control of tuberculosis","volume":"1","author":"Kaufmann","year":"2001","journal-title":". Nat Rev Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/nri2343","article-title":"How regulatory T cells work","volume":"8","author":"Vignali","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-0472","article-title":"A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment","volume":"13","author":"Strauss","year":"2007","journal-title":"Clin Cancer Res"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1086\/654896","article-title":"CD4(+) regulatory T cells in a cynomolgus macaque model of Mycobacterium tuberculosis infection","volume":"202","author":"Green","year":"2010","journal-title":"J Infect Dis"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2009.080941","article-title":"Compartmentalization of immune responses in human tuberculosis: few CD8+ effector T cells but elevated levels of FoxP3+ regulatory t cells in the granulomatous lesions","volume":"174","author":"Rahman","year":"2009","journal-title":"Am J Pathol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-01121-x","article-title":"The immunoregulatory landscape of human tuberculosis granulomas","volume":"23","author":"McCaffrey","year":"2022","journal-title":"Nat Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1172\/JCI136288","article-title":"Therapies for tuberculosis and AIDS: myeloid-derived suppressor cells in focus","volume":"130","author":"Dorhoi","year":"2020","journal-title":"J Clin Invest"},{"key":"B46","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.cell.2016.09.031","article-title":"L-arginine modulates T cell metabolism and enhances survival and anti-tumor activity","volume":"167","author":"Geiger","year":"2016","journal-title":"Cell"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201302-0249OC","article-title":"Increased frequency of myeloid-derived suppressor cells during active tuberculosis and after recent mycobacterium tuberculosis infection suppresses T-cell function","volume":"188","author":"du Plessis","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00917","article-title":"The emerging role of myeloid-derived suppressor cells in tuberculosis","volume":"10","author":"Magcwebeba","year":"2019","journal-title":"Front Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/s41392-023-01522-4","article-title":"Immune checkpoint therapy for solid tumours: clinical dilemmas and future trends","volume":"8","author":"Sun","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12967-020-02267-2","article-title":"Comprehensive analysis of the association between tumor glycolysis and immune\/inflammation function in breast cancer","volume":"18","author":"Li","year":"2020","journal-title":"J Transl Med"},{"key":"B52","doi-asserted-by":"publisher","first-page":"e","DOI":"10.1038\/cddis.2015.162","article-title":"T-cell exhaustion in the tumor microenvironment","volume":"6","author":"Jiang","year":"2015","journal-title":"Cell Death Dis"},{"key":"B53","doi-asserted-by":"publisher","first-page":"e","DOI":"10.1371\/journal.ppat.1005490","article-title":"TIM3 Mediates T Cell Exhaustion during Mycobacterium tuberculosis Infection","volume":"12","author":"Jayaraman","year":"2016","journal-title":"PloS Pathog"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1080\/1040841X.2016.1185603","article-title":"T-cell exhaustion in tuberculosis: pitfalls and prospects","volume":"43","author":"Khan","year":"2017","journal-title":"Crit Rev Microbiol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2017.05.74","article-title":"Decreased expression of perforin in CD8(+) T lymphocytes in patients with Mycobacterium tuberculosis infection and its potential value as a marker for efficacy of treatment","volume":"9","author":"Jiang","year":"2017","journal-title":"J Thorac Dis"},{"key":"B56","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/cei.12392","article-title":"Lung cancer is associated with decreased expression of perforin, granzyme B and interferon (IFN)-gamma by infiltrating lung tissue T cells, natural killer (NK) T-like and NK cells","volume":"178","author":"Hodge","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.7150\/jca.97898","article-title":"Tuberculosis to lung cancer: application of tuberculosis signatures in identification of lung adenocarcinoma subtypes and marker screening","volume":"15","author":"Feng","year":"2024","journal-title":"J Cancer"},{"key":"B58","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","article-title":"Inflammation and cancer: triggers, mechanisms, and consequences","volume":"51","author":"Greten","year":"2019","journal-title":"Immunity"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathmechdis-032221-115501","article-title":"Innate immunity and cancer pathophysiology","volume":"17","author":"Maiorino","year":"2022","journal-title":"Annu Rev Pathol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1059725","article-title":"Reinventing the human tuberculosis (TB) granuloma: Learning from the cancer field","volume":"13","author":"Ashenafi","year":"2022","journal-title":"Front Immunol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/s42003-022-03387-9","article-title":"Human M1 macrophages express unique innate immune response genes after mycobacterial infection to defend against tuberculosis","volume":"5","author":"Khan","year":"2022","journal-title":"Commun Biol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12929-019-0568-z","article-title":"Tumor-associated macrophages: an accomplice in solid tumor progression","volume":"26","author":"Chen","year":"2019","journal-title":"J BioMed Sci"},{"key":"B63","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","article-title":"Macrophage activation and polarization: nomenclature and experimental guidelines","volume":"41","author":"Murray","year":"2014","journal-title":"Immunity"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00532","article-title":"Metabolism via arginase or nitric oxide synthase: two competing arginine pathways in macrophages","volume":"5","author":"Rath","year":"2014","journal-title":"Front Immunol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.26429","article-title":"Macrophage plasticity, polarization, and function in health and disease","volume":"233","author":"Shapouri-Moghaddam","year":"2018","journal-title":"J Cell Physiol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.cell.2018.09.030","article-title":"High-dimensional analysis delineates myeloid and lymphoid compartment remodeling during successful immune-checkpoint cancer therapy","volume":"175","author":"Gubin","year":"2018","journal-title":"Cell"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20221392","article-title":"Spatial mapping reveals granuloma diversity and histopathological superstructure in human tuberculosis","volume":"220","author":"Sawyer","year":"2023","journal-title":"J Exp Med"},{"key":"B68","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12929-022-00879-y","article-title":"Spatial multi-omics analyses of the tumor immune microenvironment","volume":"29","author":"Hsieh","year":"2022","journal-title":"J BioMed Sci"},{"key":"B69","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.immuni.2022.04.004","article-title":"Multimodal profiling of lung granulomas in macaques reveals cellular correlates of tuberculosis control","volume":"55","author":"Gideon","year":"2022","journal-title":"Immunity"},{"key":"B70","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/s41392-023-01442-3","article-title":"Signaling pathways in cancer metabolism: mechanisms and therapeutic targets","volume":"8","author":"You","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1111\/imm.13276","article-title":"Targeting immunometabolism in host defence against Mycobacterium tuberculosis","volume":"162","author":"Sheedy","year":"2021","journal-title":"Immunology"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2020.04.010","article-title":"Immunometabolism during Mycobacterium tuberculosis Infection","volume":"28","author":"Howard","year":"2020","journal-title":"Trends Microbiol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nri.2017.22","article-title":"Immunometabolism and the land of milk and honey","volume":"17","author":"O\u2019Neill","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1074\/jbc.R115.693903","article-title":"Immunometabolism: cellular metabolism turns immune regulator","volume":"291","author":"Loftus","year":"2016","journal-title":"J Biol Chem"},{"key":"B75","doi-asserted-by":"publisher","first-page":"89","DOI":"10.2174\/1568010023344913","article-title":"Inducible nitric oxide synthase\u2013time for reappraisal","volume":"1","author":"Lirk","year":"2002","journal-title":"Curr Drug Targets Inflammation Allergy"},{"key":"B76","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.it.2017.03.001","article-title":"Macrophage immunometabolism: where are we (Going)","volume":"38","author":"Van den Bossche","year":"2017","journal-title":"Trends Immunol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"dmm034462","DOI":"10.1242\/dmm.034462","article-title":"The metabolic axis of macrophage and immune cell polarization","volume":"11","author":"Hobson-Gutierrez","year":"2018","journal-title":"Dis Model Mech"},{"key":"B78","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.canlet.2019.03.015","article-title":"Metabolic reprogramming of macrophages during infections and cancer","volume":"452","author":"Wang","year":"2019","journal-title":"Cancer Lett"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00067","article-title":"Impact of l-arginine metabolism on immune response and anticancer immunotherapy","author":"Kim","year":"2018","journal-title":"Front Oncol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1408839111","article-title":"Macrophage arginase-1 controls bacterial growth and pathology in hypoxic tuberculosis granulomas","volume":"111","author":"Duque-Correa","year":"2014","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgw127","article-title":"Reexamining cancer metabolism: lactate production for carcinogenesis could be the purpose and explanation of the Warburg Effect","volume":"38","author":"San-Millan","year":"2017","journal-title":"Carcinogenesis"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-018-0226-8","article-title":"Tumor immunoevasion via acidosis-dependent induction of regulatory tumor-associated macrophages","volume":"19","author":"Bohn","year":"2018","journal-title":"Nat Immunol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1678-1","article-title":"Metabolic regulation of gene expression by histone lactylation","volume":"574","author":"Zhang","year":"2019","journal-title":"Nature"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.ccell.2023.05.015","article-title":"Heymach: MCT4-dependent lactate secretion suppresses antitumor immunity in LKB1-deficient lung adenocarcinoma","volume":"41","author":"Qian","year":"2023","journal-title":"Cancer Cell"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-03045-2","article-title":"Metabolic support of tumour-infiltrating regulatory T cells by lactic acid","volume":"591","author":"Watson","year":"2021","journal-title":"Nature"},{"key":"B86","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41556-018-0083-6","article-title":"Cancer-cell-secreted exosomal miR-105 promotes tumour growth through the MYC-dependent metabolic reprogramming of stromal cells","volume":"20","author":"Yan","year":"2018","journal-title":"Nat Cell Biol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ccell.2022.01.001","article-title":"Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments","volume":"40","author":"Kumagai","year":"2022","journal-title":"Cancer Cell"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2024.04.002","article-title":"Alanyl-tRNA synthetase, AARS1, is a lactate sensor and lactyltransferase that lactylates p53 and contributes to tumorigenesis","volume":"187","author":"Zong","year":"2024","journal-title":"Cell"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-07620-9","article-title":"NBS1 lactylation is required for efficient DNA repair and chemotherapy resistance","volume":"631","author":"Chen","year":"2024","journal-title":"Nature"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-015-0534-0","article-title":"Immunometabolism within the tuberculosis granuloma: amino acids, hypoxia, and cellular respiration","volume":"38","author":"Qualls","year":"2016","journal-title":"Semin Immunopathol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1501612","article-title":"Cutting edge: mycobacterium tuberculosis induces aerobic glycolysis in human alveolar macrophages that is required for control of intracellular bacillary replication","volume":"196","author":"Gleeson","year":"2016","journal-title":"J Immunol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1021\/pr2003352","article-title":"Metabolic profiling of lung granuloma in Mycobacterium tuberculosis infected Guinea pigs: ex vivo 1H magic angle spinning NMR studies","volume":"10","author":"Somashekar","year":"2011","journal-title":"J Proteome Res"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1021\/pr300345x","article-title":"Metabolomic signatures in Guinea pigs infected with epidemic-associated W-Beijing strains of Mycobacterium tuberculosis","volume":"11","author":"Somashekar","year":"2012","journal-title":"J Proteome Res"},{"key":"B94","doi-asserted-by":"publisher","first-page":"6484","DOI":"10.1038\/s41598-017-05916-7","article-title":"Lactate oxidation facilitates growth of Mycobacterium tuberculosis in human macrophages","volume":"7","author":"Billig","year":"2017","journal-title":"Sci Rep"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.624607","article-title":"Lactate metabolism and signaling in tuberculosis and cancer: A comparative review","volume":"11","author":"Kiran","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-020-0273-y","article-title":"Metabolism of immune cells in cancer","volume":"20","author":"Leone","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"B97","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12964-022-00909-0","article-title":"Reprogramming of glutamine metabolism and its impact on immune response in the tumor microenvironment","volume":"20","author":"Ma","year":"2022","journal-title":"Cell Commun Signal"},{"key":"B98","doi-asserted-by":"publisher","first-page":"7427","DOI":"10.1038\/s41467-023-43304-0","article-title":"Glutamine metabolism inhibition has dual immunomodulatory and antibacterial activities against Mycobacterium tuberculosis","volume":"14","author":"Parveen","year":"2023","journal-title":"Nat Commun"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.71.1.456-464.2003","article-title":"Inhibition of Mycobacterium tuberculosis glutamine synthetase as a novel antibiotic strategy against tuberculosis: demonstration of efficacy in vivo","volume":"71","author":"Harth","year":"2003","journal-title":"Infect Immun"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2958.2005.04899.x","article-title":"All four Mycobacterium tuberculosis glnA genes encode glutamine synthetase activities but only GlnA1 is abundantly expressed and essential for bacterial homeostasis","volume":"58","author":"Harth","year":"2005","journal-title":"Mol Microbiol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s00281-020-00798-w","article-title":"Immunometabolism: new insights and lessons from antigen-directed cellular immune responses","volume":"42","author":"Ramalho","year":"2020","journal-title":"Semin Immunopathol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41392-023-01722-y","article-title":"Lung microbiome: new insights into the pathogenesis of respiratory diseases","volume":"9","author":"Li","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1003304","article-title":"CD4 T cells promote rather than control tuberculosis in the absence of PD-1-mediated inhibition","volume":"186","author":"Barber","year":"2011","journal-title":"J Immunol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005667","article-title":"CD4 T cell-derived IFN-gamma plays a minimal role in control of pulmonary mycobacterium tuberculosis infection and must be actively repressed by PD-1 to prevent lethal disease","volume":"12","author":"Sakai","year":"2016","journal-title":"PloS Pathog"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abf3861","article-title":"PD-1 blockade exacerbates Mycobacterium tuberculosis infection in rhesus macaques","volume":"6","author":"Kauffman","year":"2021","journal-title":"Sci Immunol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01995","article-title":"PD-1 expression on mycobacterium tuberculosis-specific CD4 T cells is associated with bacterial load in human tuberculosis","volume":"1995","author":"Day","year":"2018","journal-title":"Front Immunol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.52668","article-title":"Anti-PD-1 immunotherapy leads to tuberculosis reactivation via dysregulation of TNF-alpha","volume":"9","author":"Tezera","year":"2020","journal-title":"Elife"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(15)00135-8","article-title":"Permutations of time and place in tuberculosis","volume":"15","author":"Elkington","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.03.022","article-title":"TNF dually mediates resistance and susceptibility to mycobacteria via mitochondrial reactive oxygen species","volume":"153","author":"Roca","year":"2013","journal-title":"Cell"},{"key":"B110","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1016\/j.cell.2019.08.004","article-title":"TNF induces pathogenic programmed macrophage necrosis in tuberculosis through a mitochondrial-lysosomal-endoplasmic reticulum circuit","volume":"178","author":"Roca","year":"2019","journal-title":"Cell"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-07866-3","article-title":"Tuberculosis in otherwise healthy adults with inherited TNF deficiency","volume":"633","author":"Arias","year":"2024","journal-title":"Nature"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1703481","article-title":"Immune-related adverse events associated with immune checkpoint blockade","volume":"378","author":"Postow","year":"2018","journal-title":"N Engl J Med"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2016.09.007","article-title":"Tuberculosis: an infection-initiated autoimmune disease","volume":"37","author":"Elkington","year":"2016","journal-title":"Trends Immunol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211560","article-title":"Successful treatment of arthritis induced by checkpoint inhibitors with tocilizumab: a case series","volume":"76","author":"Kim","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B115","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nri.2017.112","article-title":"Immune checkpoint blockade in infectious diseases","volume":"18","author":"Wykes","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20070608","article-title":"Role of the chemokine decoy receptor D6 in balancing inflammation, immune activation, and antimicrobial resistance in Mycobacterium tuberculosis infection","volume":"205","author":"Di Liberto","year":"2008","journal-title":"J Exp Med"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.5.3119","article-title":"Damping excessive inflammation and tissue damage in Mycobacterium tuberculosis infection by Toll IL-1 receptor 8\/single Ig IL-1-related receptor, a negative regulator of IL-1\/TLR signaling","volume":"179","author":"Garlanda","year":"2007","journal-title":"J Immunol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiv076","article-title":"The extracellular matrix regulates granuloma necrosis in tuberculosis","volume":"212","author":"Al Shammari","year":"2015","journal-title":"J Infect Dis"},{"key":"B119","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.immuni.2017.08.003","article-title":"Phenolic glycolipid facilitates mycobacterial escape from microbicidal tissue-resident macrophages","volume":"47","author":"Cambier","year":"2017","journal-title":"Immunity"},{"key":"B120","doi-asserted-by":"publisher","first-page":"17072","DOI":"10.1038\/nmicrobiol.2017.72","article-title":"Nitric oxide prevents a pathogen-permissive granulocytic inflammation during tuberculosis","volume":"2","author":"Mishra","year":"2017","journal-title":"Nat Microbiol"},{"key":"B121","doi-asserted-by":"publisher","first-page":"2102512","DOI":"10.1183\/13993003.02512-2021","article-title":"The paradox of immune checkpoint inhibition re-activating tuberculosis","volume":"60","author":"Ahmed","year":"2022","journal-title":"Eur Respir J"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2021-217260","article-title":"Infections due to dysregulated immunity: an emerging complication of cancer immunotherapy","volume":"77","author":"Morelli","year":"2022","journal-title":"Thorax"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.107881","article-title":"Immunotherapy and biomarkers in patients with lung cancer with tuberculosis: Recent advances and future Directions","volume":"26","author":"Yang","year":"2023","journal-title":"iScience"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.2217\/imt-2020-0061","article-title":"Reactivation of TB during administration of durvalumab after chemoradiotherapy for non-small-cell lung cancer: a case report","volume":"12","author":"Kato","year":"2020","journal-title":"Immunotherapy"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2019-213913","article-title":"Tuberculosis associated with Triplet therapy for lung cancer","volume":"75","author":"Crawley","year":"2020","journal-title":"Thorax"},{"key":"B126","article-title":"Impact of adjuvant chemotherapy on spontaneous and poke week mitogen triggered immunoglobulin secretion of blood lymphocytes in operable breast cancer","volume":"8","author":"Blomgren","year":"1988","journal-title":"Anticancer Res"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2021.01.034","article-title":"Risk and impact of radiation related lymphopenia in lung cancer: A systematic review and meta-analysis","volume":"157","author":"Upadhyay","year":"2021","journal-title":"Radiother Oncol"},{"key":"B128","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.ijrobp.2020.01.032","article-title":"Absolute lymphocyte count predicts abscopal responses and outcomes in patients receiving combined immunotherapy and radiation therapy: analysis of 3 phase 1\/2 trials","volume":"108","author":"Chen","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B129","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.lungcan.2021.01.022","article-title":"Association of severe lymphopenia and disease progression in unresectabl e locally advanced non-small cell lung cancer treated with definitive chemoradiation and immunotherapy","volume":"154","author":"Friedes","year":"2021","journal-title":"Lung Cancer"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-010-9396-4","article-title":"Escalating weekly doses of cetuximab and correlation with skin toxicity: a phase I study","volume":"29","author":"Ho","year":"2011","journal-title":"Invest New Drugs"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1097\/SPC.0b013e32832e4681","article-title":"Management of sorafenib, sunitinib, and temsirolimus toxicity in metastatic renal cell carcinoma","volume":"3","author":"Guevremont","year":"2009","journal-title":"Curr Opin Support Palliat Care"},{"key":"B132","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1038\/s41467-024-45769-z","article-title":"Sintilimab with two cycles of chemotherapy for the treatment of advanced squamous non-small cell lung cancer: a phase 2 clinical trial","volume":"15","author":"Zhang","year":"2024","journal-title":"Nat Commun"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.6837","article-title":"Neoadjuvant chemo-immunotherapy for early-stage non-small cell lung cancer: A systematic review and meta-analysis","volume":"7","author":"Banna","year":"2024","journal-title":"JAMA Netw Open"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2024.0057","article-title":"Neoadjuvant chemoimmunotherapy for NSCLC: A systematic review and meta-analysis","volume":"10","author":"Sorin","year":"2024","journal-title":"JAMA Oncol"},{"key":"B135","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/s41392-022-01102-y","article-title":"Radiotherapy combined with immunotherapy: the dawn of cancer treatment","volume":"7","author":"Zhang","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2019.08.047","article-title":"Impact of treatment-related lymphopenia on immunotherapy for advanced non-small cell lung cancer","volume":"105","author":"Cho","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2015.0151","article-title":"Survival in patients with severe lymphopenia following treatment with radiation and chemotherapy for newly diagnosed solid tumors","volume":"13","author":"Grossman","year":"2015","journal-title":"J Natl Compr Canc Netw"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.3109\/07357907.2013.767342","article-title":"Treatment-related lymphopenia in patients with stage III non-small-cell lung cancer","volume":"31","author":"Campian","year":"2013","journal-title":"Cancer Invest"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-0774","article-title":"Immunosuppression in patients with high-grade gliomas treated with radiation and temozolomide","volume":"17","author":"Grossman","year":"2011","journal-title":"Clin Cancer Res"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1177\/15330338221112287","article-title":"Shortened radiation time promotes recovery from radiation-induced lymphopenia in early-stage non-small cell lung cancer patients treated with stereotactic body radiation therapy","volume":"21","author":"Zhao","year":"2022","journal-title":"Technol Cancer Res Treat"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab729","article-title":"Neutrophils contribute to severity of tuberculosis pathology and recovery from lung damage pre- and posttreatment","volume":"74","author":"Nwongbouwoh Muefong","year":"2022","journal-title":"Clin Infect Dis"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00962","article-title":"Neutrophils in tuberculosis-associated inflammation and lung pathology","volume":"11","author":"Muefong","year":"2020","journal-title":"Front Immunol"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M113.510495","article-title":"NADPH oxidase-generated hydrogen peroxide induces DNA damage in mutant FLT3-expressing leukemia cells","volume":"290","author":"Stanicka","year":"2015","journal-title":"J Biol Chem"},{"key":"B144","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.semcdb.2017.05.023","article-title":"ROS signalling in the biology of cancer","volume":"80","author":"Moloney","year":"2018","journal-title":"Semin Cell Dev Biol"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.21037\/tlcr-21-465","article-title":"Advances in molecular mechanisms of interaction between Mycobacterium tuberculosis and lung cancer: a narrative review","volume":"10","author":"Xiong","year":"2021","journal-title":"Transl Lung Cancer Res"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2022.101672","article-title":"Inflammation-mediated tissue damage in pulmonary tuberculosis and host-directed therapeutic strategies","volume":"65","author":"Tiwari","year":"2023","journal-title":"Semin Immunol"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00012.2018","article-title":"The neutrophil\u2019s role during health and disease","volume":"99","author":"Liew","year":"2019","journal-title":"Physiol Rev"},{"key":"B149","doi-asserted-by":"publisher","first-page":"4801","DOI":"10.3390\/ijms22094801","article-title":"Neutrophils in tuberculosis: cell biology, cellular networking and multitasking in host defense","volume":"22","author":"Borkute","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B150","doi-asserted-by":"publisher","first-page":"5566","DOI":"10.1038\/s41467-020-19412-6","article-title":"Type I IFN exacerbates disease in tuberculosis-susceptible mice by inducing neutrophil-mediated lung inflammation and NETosis","volume":"11","author":"Moreira-Teixeira","year":"2020","journal-title":"Nat Commun"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2015.03.007","article-title":"Neutrophils exacerbate tuberculosis infection in genetically susceptible mice","volume":"95","author":"Yeremeev","year":"2015","journal-title":"Tuberculosis (Edinb)"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20110919","article-title":"Regulation of neutrophils by interferon-gamma limits lung inflammation during tuberculosis infection","volume":"208","author":"Nandi","year":"2011","journal-title":"J Exp Med"},{"key":"B153","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.chom.2017.09.003","article-title":"M. tuberculosis-induced necrosis of infected neutrophils promotes bacterial growth following phagocytosis by macrophages","volume":"22","author":"Dallenga","year":"2017","journal-title":"Cell Host Microbe"},{"key":"B154","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1159\/000348676","article-title":"Mycobacterium tuberculosis- induced neutrophil extracellular traps activate human macrophages","volume":"5","author":"Braian","year":"2013","journal-title":"J Innate Immun"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2987","article-title":"Neutrophils sense microbe size and selectively release neutrophil extracellular traps in response to large pathogens","volume":"15","author":"Branzk","year":"2014","journal-title":"Nat Immunol"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2016.52","article-title":"Neutrophils in cancer: neutral no more","volume":"16","author":"Coffelt","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-024-03004-5","article-title":"Neutrophils in cancer: dual roles through intercellular interactions","volume":"43","author":"Yu","year":"2024","journal-title":"Oncogene"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-0915-y","article-title":"Neutrophils escort circulating tumour cells to enable cell cycle progression","volume":"566","author":"Szczerba","year":"2019","journal-title":"Nature"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-19-1972","article-title":"Circulating tumor cell-neutrophil tango along the metastatic process","volume":"79","author":"Saini","year":"2019","journal-title":"Cancer Res"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-10-1166","article-title":"Increased risk of lung cancer in men with tuberculosis in the alpha-tocopherol, beta-carotene cancer prevention study","volume":"20","author":"Shiels","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2009.32","article-title":"Lung carcinogenesis induced by chronic tuberculosis infection: the experimental model and genetic control","volume":"28","author":"Nalbandian","year":"2009","journal-title":"Oncogene"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.168.21.2326","article-title":"Lung cancer risk following detection of pulmonary scarring by chest radiography in the prostate, lung, colorectal, and ovarian cancer screening trial","volume":"168","author":"Yu","year":"2008","journal-title":"Arch Intern Med"},{"key":"B163","doi-asserted-by":"publisher","first-page":"687","DOI":"10.3390\/cancers13040687","article-title":"Tuberculous fibrosis enhances tumorigenic potential via the NOX4-autophagy axis","volume":"13","author":"Woo","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00127","article-title":"Mechanisms driving macrophage diversity and specialization in distinct tumor microenvironments and parallelisms with other tissues","author":"Van Overmeire","year":"2014","journal-title":"Front Immunol"},{"key":"B165","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1038\/s41467-018-04355-w","article-title":"Factor XIIIA-expressing inflammatory monocytes promote lung squamous cancer through fibrin cross-linking","volume":"9","author":"Porrello","year":"2018","journal-title":"Nat Commun"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.7150\/jca.30300","article-title":"Scar tissue to lung cancer; pathways and treatment","volume":"10","author":"Sapalidis","year":"2019","journal-title":"J Cancer"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111797","article-title":"Recruited monocytes\/macrophages drive pulmonary neutrophilic inflammation and irreversible lung tissue remodeling in cystic fibrosis","volume":"41","author":"Oz","year":"2022","journal-title":"Cell Rep"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.688625","article-title":"The role of tumor inflammatory microenvironment in lung cancer","volume":"12","author":"Tan","year":"2021","journal-title":"Front Pharmacol"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1038\/nature10138","article-title":"CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis","volume":"475","author":"Qian","year":"2011","journal-title":"Nature"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008459","article-title":"CCL2 responses to Mycobacterium tuberculosis are associated with disease severity in tuberculosis","volume":"4","author":"Hasan","year":"2009","journal-title":"PloS One"},{"key":"B171","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1186\/s12935-023-03095-2","article-title":"Microbiome modulation in inflammatory diseases: Progress to microbiome genetic engineering","volume":"23","author":"Mousavinasab","year":"2023","journal-title":"Cancer Cell Int"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-022-00698-4","article-title":"Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications","volume":"20","author":"Zhang","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B173","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1093\/advances\/nmac052","article-title":"Nutrition, immunosenescence, and infectious disease: an overview of the scientific evidence on micronutrients and on modulation of the gut microbiota","volume":"13","author":"Calder","year":"2022","journal-title":"Adv Nutr"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2020.1737487","article-title":"Specific gut microbiome signature predicts the early-stage lung cancer","volume":"11","author":"Zheng","year":"2020","journal-title":"Gut Microbes"},{"key":"B175","doi-asserted-by":"publisher","first-page":"546","DOI":"10.3390\/microorganisms11030546","article-title":"Association studies on gut and lung microbiomes in patients with lung adenocarcinoma","volume":"11","author":"Guo","year":"2023","journal-title":"Microorganisms"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.725284","article-title":"Specific gut microbiome and serum metabolome changes in lung cancer patients","volume":"11","author":"Zhao","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"B177","article-title":"The microbiome of lung cancer tissue and its association with pathological and clinical parameters","volume":"12","author":"Kim","year":"2022","journal-title":"Am J Cancer Res"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2022.2029997","article-title":"The gut microbiota mediates protective immunity against tuberculosis via modulation of lncRNA","volume":"14","author":"Yang","year":"2022","journal-title":"Gut Microbes"},{"key":"B179","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/s41467-021-21475-y","article-title":"Gastrointestinal microbiota composition predicts peripheral inflammatory state during treatment of human tuberculosis","volume":"12","author":"Wipperman","year":"2021","journal-title":"Nat Commun"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adi9711","article-title":"Commensal antimicrobial resistance mediates microbiome resilience to antibiotic disruption","volume":"16","author":"Bhattarai","year":"2024","journal-title":"Sci Transl Med"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268822000176","article-title":"Comparison of clinical and imaging features between pulmonary tuberculosis complicated with lung cancer and simple pulmonary tuberculosis: a systematic review and meta-analysis","volume":"150","author":"Sun","year":"2022","journal-title":"Epidemiol Infect"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(22)00087-8","article-title":"CRISPR detection of circulating cell-free Mycobacterium tuberculosis DNA in adults and children, including children with HIV: a molecular diagnostics study","volume":"3","author":"Huang","year":"2022","journal-title":"Lancet Microbe"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1038\/s41551-022-00922-1","article-title":"Diagnosis of paediatric tuberculosis by optically detecting two virulence factors on extracellular vesicles in blood samples","volume":"6","author":"Zheng","year":"2022","journal-title":"Nat BioMed Eng"},{"key":"B184","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41523-024-00626-6","article-title":"Circulating tumor DNA validity and potential uses in metastatic breast cancer","volume":"10","author":"Amato","year":"2024","journal-title":"NPJ Breast Cancer"},{"key":"B185","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1038\/s41467-024-45475-w","article-title":"Prediction of plasma ctDNA fraction and prognostic implications of liquid biopsy in advanced prostate cancer","volume":"15","author":"Fonseca","year":"2024","journal-title":"Nat Commun"},{"key":"B186","doi-asserted-by":"publisher","first-page":"13559","DOI":"10.1038\/s41598-021-92667-1","article-title":"PGE2 displays immunosuppressive effects during human active tuberculosis","volume":"11","author":"Pellegrini","year":"2021","journal-title":"Sci Rep"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1172\/JCI23949","article-title":"Host control of Mycobacterium tuberculosis is regulated by 5-lipoxygenase-dependent lipoxin production","volume":"115","author":"Bafica","year":"2005","journal-title":"J Clin Invest"},{"key":"B188","doi-asserted-by":"publisher","first-page":"993","DOI":"10.4103\/0028-3886.266232","article-title":"Role of aspirin in tuberculous meningitis: A systematic review and meta-analysis","volume":"67","author":"Rizvi","year":"2019","journal-title":"Neurol India"},{"key":"B189","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1093\/infdis\/jit152","article-title":"Ibuprofen therapy resulted in significantly decreased tissue bacillary loads and increased survival in a new murine experimental model of active tuberculosis","volume":"208","author":"Vilaplana","year":"2013","journal-title":"J Infect Dis"},{"key":"B190","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(10)62110-1","article-title":"Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials","volume":"377","author":"Rothwell","year":"2011","journal-title":"Lancet"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1007\/s10552-011-9847-z","article-title":"Aspirin and NSAID use and lung cancer risk: a pooled analysis in the International Lung Cancer Consortium (ILCCO)","volume":"22","author":"McCormack","year":"2011","journal-title":"Cancer Causes Control"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32247-X","article-title":"Effect of interleukin-1beta inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial","volume":"390","author":"Ridker","year":"2017","journal-title":"Lancet"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1152\/physiol.00024.2006","article-title":"The mTOR pathway in the control of protein synthesis","volume":"21","author":"Wang","year":"2006","journal-title":"Physiol (Bethesda)"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.25898","article-title":"Glutamate increases pancreatic cancer cell invasion and migration via AMPA receptor activation and Kras-MAPK signaling","volume":"129","author":"Herner","year":"2011","journal-title":"Int J Cancer"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA118.006378","article-title":"Ablation of the ASCT2 (SLC1A5) gene encoding a neutral amino acid transporter reveals transporter plasticity and redundancy in cancer cells","volume":"294","author":"Broer","year":"2019","journal-title":"J Biol Chem"},{"key":"B196","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/nm.4464","article-title":"Pharmacological blockade of ASCT2-dependent glutamine transport leads to antitumor efficacy in preclinical models","volume":"24","author":"Schulte","year":"2018","journal-title":"Nat Med"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-018-0307-z","article-title":"xCT (SLC7A11)-mediated metabolic reprogramming promotes non-small cell lung cancer progression","volume":"37","author":"Ji","year":"2018","journal-title":"Oncogene"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1311939110","article-title":"Emergence of spatial structure in the tumor microenvironment due to the Warburg effect","volume":"110","author":"Carmona-Fontaine","year":"2013","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B199","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1038\/s41467-019-09816-4","article-title":"Spatial and temporal localization of immune transcripts defines hallmarks and diversity in the tuberculosis granuloma","volume":"10","author":"Carow","year":"2019","journal-title":"Nat Commun"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1424563112","article-title":"Anti-vascular endothelial growth factor treatment normalizes tuberculosis granuloma vasculature and improves small molecule delivery","volume":"112","author":"Datta","year":"2015","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1011847","article-title":"Mathematical model of oxygen, nutrient, and drug transport in tuberculosis granulomas","volume":"20","author":"Datta","year":"2024","journal-title":"PloS Comput Biol"},{"key":"B202","first-page":"1","article-title":"Redox proteins of mycobacterium tuberculosis","volume":"94","author":"Phulera","year":"2014","journal-title":"J Indian Institute Sci"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.108272","article-title":"Auranofin: past to present, and repurposing","volume":"101","author":"Yamashita","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1039\/d3md00058c","article-title":"Mycobacterium tuberculosis CitA activity is modulated by cysteine oxidation and pyruvate binding","volume":"14","author":"Pathirage","year":"2023","journal-title":"RSC Med Chem"},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.1039\/c9cc04145a","article-title":"Targeting the Mycobacterium tuberculosis transpeptidase Ldt(Mt2) with cysteine-reactive inhibitors including ebselen","volume":"55","author":"de Munnik","year":"2019","journal-title":"Chem Commun (Camb)"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1561719\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T02:42:34Z","timestamp":1743561754000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1561719\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,2]]},"references-count":205,"alternative-id":["10.3389\/fimmu.2025.1561719"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1561719","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,2]]},"article-number":"1561719"}}